Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (371-380 of 561) with videos related to

Pageof 57
Sort By:
Minerva Urology and Nephrology|July 15, 2021
Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-upChiara Lonati, Francesco Esperto, Roberto M Scarpa, et al.
European Urology|September 25, 2019
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 18, 2021
Available evidence on HIFU for focal treatment of prostate cancer: a systematic reviewArnas Bakavicius, Giancarlo Marra, Petr Macek, et al.
Clinical Genitourinary Cancer|February 13, 2023
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical CystectomyMarkus von Deimling, Victor M Schuettfort, David D'Andrea, et al.
European Urology Oncology|July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial CarcinomaRenate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Arab Journal of Urology|March 25, 2021
Assessment of the oncological outcomes of three different bacillus Calmette-Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancerŁukasz Nowak, Wojciech Krajewski, Marco Moschini, et al.
European Urology Focus|June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery GuidelinesJudith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Clinical Genitourinary Cancer|February 7, 2022
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter StudyNico C Grossmann, Benjamin Pradere, David D'Andrea, et al.
Minerva Urology and Nephrology|March 22, 2023
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic reviewGiuseppe Basile, Mario de Angelis, Riccardo Leni, et al.
BJU International|October 7, 2023
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancerAndrea Necchi, Giuseppe Basile, Ewan A Gibb, et al.
Pageof 57

Showing results (371-380 of 561) with videos related to

Sort By:
Pageof 57
Minerva Urology and Nephrology|July 15, 2021
Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-upChiara Lonati, Francesco Esperto, Roberto M Scarpa, et al.
European Urology|September 25, 2019
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 18, 2021
Available evidence on HIFU for focal treatment of prostate cancer: a systematic reviewArnas Bakavicius, Giancarlo Marra, Petr Macek, et al.
Clinical Genitourinary Cancer|February 13, 2023
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical CystectomyMarkus von Deimling, Victor M Schuettfort, David D'Andrea, et al.
European Urology Oncology|July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial CarcinomaRenate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Arab Journal of Urology|March 25, 2021
Assessment of the oncological outcomes of three different bacillus Calmette-Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancerŁukasz Nowak, Wojciech Krajewski, Marco Moschini, et al.
European Urology Focus|June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery GuidelinesJudith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Clinical Genitourinary Cancer|February 7, 2022
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter StudyNico C Grossmann, Benjamin Pradere, David D'Andrea, et al.
Minerva Urology and Nephrology|March 22, 2023
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic reviewGiuseppe Basile, Mario de Angelis, Riccardo Leni, et al.
BJU International|October 7, 2023
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancerAndrea Necchi, Giuseppe Basile, Ewan A Gibb, et al.
Pageof 57